Description

Cabozantinib Impurity Exa is a designated impurity standard used in the pharmaceutical development and quality control of the active pharmaceutical ingredient (API) Cabozantinib. This high-purity reference material is critical for ensuring the safety, efficacy, and regulatory compliance of the final drug product by enabling accurate identification and quantification of this specific impurity. It is an essential tool for analytical laboratories, research institutions, and pharmaceutical manufacturers engaged in method development, stability studies, and batch release testing for Cabozantinib-based formulations.

Application

• Pharmaceutical Reference Standard: Primary use as a certified reference material for the qualitative and quantitative analysis of Cabozantinib.
• Analytical Method Development and Validation: Used to develop, optimize, and validate HPLC, UPLC, or LC-MS methods for impurity profiling.
• Quality Control and Batch Release: Serves as a system suitability and identification standard in the routine QC testing of Cabozantinib API to monitor impurity levels against ICH guidelines.
• Stability Studies: Employed to track the formation and growth of this specific impurity under various stress conditions (e.g., heat, light, humidity) as per ICH stability protocols.
• Regulatory Submissions: Provides essential data for regulatory filings (e.g., FDA, EMA) to establish impurity thresholds and justify specifications.
• Research and Development: Used in synthetic route optimization and process chemistry to understand and minimize the formation of this impurity.

Basic Information

Product Name	Cabozantinib Impurity Exa
CAS No.	1431468-36-8
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Cabozantinib Related Compound Exa; Cabozantinib Impurity; Cabozantinib EP Impurity Exa; Cabozantinib USP Impurity Exa; Cabozantinib Process Impurity; Cabozantinib Degradant; 1-N-{4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl}-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Impurity; Cabozantinib Specified Impurity
EINECS	Contact for details

Quality Control

Our Cabozantinib Impurity Exa is manufactured under strict quality systems. Each batch undergoes comprehensive analytical characterization using techniques such as HPLC, LC-MS, NMR, and IR to confirm identity and ensure high purity. A detailed Certificate of Analysis (COA) is provided with each shipment, containing batch-specific data on purity, impurities, and chromatographic profiles. Our quality commitment aligns with the standards expected for pharmaceutical reference materials.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as indicated on the label or Certificate of Analysis. Keep the container in a dry, cool, and well-ventilated place. Handle and store in accordance with good laboratory practices.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Retention time matches reference standard
Identification (IR)	Spectrum conforms to reference
Purity (HPLC)	≥ 95.0%
Related Substances (HPLC)	Individual unspecified impurity: ≤ 1.0% Total impurities: ≤ 5.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.